Abstract: The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.

Abstract: Dosage forms of sodium {4-[5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-benzoimidazole-1-sulfonyl]-phenoxy}-acetate, and methods of use of the dosage forms are disclosed herein.

Abstract: Dosage forms of sodium {4-[5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-benzoimidazole-1-sulfonyl]-phenoxy}-acetate, and methods of use of the dosage forms are disclosed herein.

Abstract: The present invention provides a method for treating infertility which may be caused by sperm immobility, comprising administering to a person in need of treatment for infertility an effective amount of a pharmaceutical composition comprising a RAR retinoid selective compound to activate sperm motility, together with a pharmaceutically acceptable excipient, and thereby providing sperm with improved motility for treating infertility.

Abstract: The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.

Abstract: Methods including systemically, preferably orally, administering retinoid components to a human or animal to provide the desired therapeutic effect and at least one fewer side effect or at least one reduced side effect.

Abstract: Methods including orally administering retinoid components to a human or animal to provide a substantially equivalent bioavailability of the retinoid component to the human or animal without regard to the body weight of the human or animal.

Abstract: Methods including orally administering retinoid components to a human or animal having nodulocystic acne to provide substantial reduction in nodulocystic acne in the human or animal and relatively little or substantially no reduction in sebum secretion in the human or animal relative to employing a reference retinoid agent, for example, a pan active retinoid agent, in an orally administering step using an amount of the reference retinoid agent to provide the same reduction in nodulocystic acne.

Abstract: The invention concerns methods and compositions related to the use of a retinoid for the treatment of nodulocystic acne.

Abstract: Methods including systemically, preferably orally, administering retinoid components to a human or animal to provide the desired therapeutic effect and at least one fewer drug interaction or at least one reduced drug interaction.

Abstract: Methods including orally administering retinoid components to a human or animal to provide a substantially equivalent bioavailability of the retinoid component to the human or animal in the presence or absence of food in the human or animal.

Abstract: The present invention provides a method for treating proliferative skin diseases comprising the administration of an effective amount of tazarotene and an effective amount of a corticosteroid. This invention is especially useful for treating psoriasis.

Abstract: The present invention relates to a method of treating psoriasis and/or photo damage in humans with tazarotene in a topical composition from 0.01 to 15% by weight tazarotene, and an alpha or beta-hydroxy acid in a topical composition comprising from 1 to 25% by weight alpha or beta-hydroxy acid. Furthermore, the present invention relates to treating or preventing psoriasis and/or photo damage by topically applying to the skin of a human, tazarotene, such as a gel comprising 0.01% to 0.1%, tazarotene by weight, and an alpha hydroxy acid, such as a cream, comprising 5% to 20% alpha hydroxy acid, e.g. glycolic acid, by weight.

Abstract: The present invention provides a method for treating acne vulgaris by serially applying a topical composition of azelaic acid and a topical composition of benzoyl peroxide. The present invention also provides topical compositions of a peroxide of benzoyl peroxide, and azelaic acid and its derivatives, such as azelaic acid, sodium salt or methylester which are useful for treating acne vulgaris and may be used to simultaneously apply benzoyl peroxide and azelaic acid.